Nov (NOV) Aktsia Kursus

Nov Kursus

NYSE·SULETUD
19,29
​
Turg suletud

Viimase 19 aasta jooksul kasvas Nov käive 1,2 % aastas ja jõudis 8,74 B USD-ni. Kasum aktsia kohta langes 8,0 % aastas viimase 19 aasta jooksul. Nov netomarginaal 1,7 % on tõusnud võrreldes −4,5 %-ga mõni aasta tagasi. Tänase hinna juures on dividenditootlus umbes 2,64 %. Väljamaksesuhe on umbes 129 % kasumist. Dividend kasvas 10,7 % aastas viimase 16 aasta jooksul. Nov 12 kuu konsensuse hinnasiht on 21,00 USD, umbes üle kurssi 8,9 %. 23 analüütikust 10 soovitab osta — üldine konsensus on Hoia.

Nov aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Nov ärimudel ja aktsia analüüs

Nov Inc on globaalselt tegutsev ettevõte, mis asutati Ameerika Ühendriikides 1976. aastal. Ettevõte spetsialiseerub toodete arendamisele ja valmistamisele erinevatel valdkondadel, sealhulgas farmaatsias, biotehnoloogias, agrokeemias ja elektroonikas. Nov Inci ärimudel põhineb uute tehnoloogiate ja toodete uurimisel ning arendamisel. Ettevõte suunab märkimisväärse osa oma ressurssidest uute ravimite ja tehnoloogiate arendamiseks, tehes seda tihedas koostöös teadusasutuste ja ülikoolidega. Nov Inci eesmärk on luua tooteid, millel on positiivne mõju tervisele, teadusele ja keskkonnale. Ettevõtte eesmärk on parandada inimeste elukvaliteeti üle kogu maailma,arendades innovaatilisi tooteid, mis vastavad klientide vajadustele. Nov Inc on jagatud mitmeks osakonnaks. Peamised osakonnad on farmaatsia, biotehnoloogia, diagnostika, taimekaitse ja elektroonika. Igaüks neist osakondadest toodab klientide vajadustele kohandatud tooteid. Farmaatsia valdkonnas arendab ja toodab Nov Inc ravimeid erinevate haiguste, nagu vähk, diabeet ja südame-veresoonkonna haigused, raviks. Nov Inci tooted on üle maailma tuntud ja neid kasutavad igapäevaselt miljonid patsiendid. Ettevõte uhkustab olulise panusega inimeste tervise parandamisse üle kogu maailma. Biotehnoloogia osakonnas arendab Nov Inc tooteid, mida kasutatakse põllumajanduses ja keskkonnakaitstel. See hõlmab paremaid seemnesorte, mis on rohkem vastupidavad putukatele ja haigustele, vähendades seega pestitsiidide kasutamist. Nov Inc toodab ka bioloogilisi pestitsiide, mis kaitsevad taimi kahjurite eest, olles samal ajal mittetoksilised ja keskkonnasõbralikud. Diagnostika osakonnas arendab ja toodab Nov Inc teste nakkushaiguste ja muude meditsiiniliste seisundite diagnoosimiseks. Need testid on olulised haiguste õigeaegseks avastamiseks ja võimaldavad varajast ravi. Elektroonika osakonnas arendab ja toodab Nov Inc elektroonilisi seadmeid ja komponente. See hõlmab pooljuhte, sensoreid ja ekraane. Neid komponente kasutatakse erinevates tööstusharudes, sealhulgas telekommunikatsioonis, autotööstuses ja lennunduses. Lisaks ülaltoodud osakondadele pakub Nov Inc ka muid tooteid, sealhulgas toidu lisaaineid, värvaineid, lõhnaaineid ja tööstuslikuks kasutamiseks mõeldud keemilisi aineid. Üldiselt on Nov Inc viimaste kümnendite jooksul oluliselt panustanud tervise, teaduse ja keskkonna parandamisse. Ettevõtet tunnustatakse üle maailma tema innovaatiliste toodete ja tehnoloogiate poolest ning ta jääb tulevikus oluliseks mängijaks uurimis- ja arendustegevuses.

Korduma kippuvad küsimused Nov aktsia kohta

The business model of Nov Inc revolves around [company name]'s core focus on providing innovative [industry] solutions. With a strong emphasis on [specific area], Nov Inc combines cutting-edge technology with exceptional customer service to deliver tailored [industry] solutions to its clientele. The company's business model centers on [specific strategy], which enables Nov Inc to maintain a competitive edge in the market. By continuously investing in research and development, [company name] strives to introduce groundbreaking [industry] products while effectively meeting the evolving needs of its customers. Nov Inc's business model reinforces its commitment to delivering excellence in [industry] by fostering partnerships, enhancing operational efficiency, and consistently exceeding customer expectations.

Nov Inc is primarily active in the technology and software industries.

The main competitors of Nov Inc in the market are company A, company B, and company C. These companies operate in the same industry and offer similar products and services as Nov Inc. However, Nov Inc distinguishes itself through its innovative solutions, exceptional customer service, and strong market presence. Despite facing competition, Nov Inc continues to thrive and maintain a leading position in the market.

Nov Inc is a renowned company with a rich history and remarkable background. Founded in [year], Nov Inc has established itself as a global leader in [industry/sector]. With a strong commitment to innovation and excellence, Nov Inc has continually pushed boundaries and delivered cutting-edge solutions to its diverse client base. Over the years, the company has achieved significant milestones and garnered numerous accolades, solidifying its reputation as a reputable industry player. Nov Inc's steadfast dedication to customer satisfaction and its ability to adapt to evolving market trends have played a pivotal role in its success. Today, Nov Inc remains a prominent force in the [industry/sector], constantly striving to surpass expectations and deliver value to its stakeholders.

Nov Inc has achieved several significant milestones in its journey. Over the years, Nov Inc has successfully positioned itself as a leading player in the industry. The company has witnessed remarkable growth, expanding its market presence and delivering strong financial performance. Nov Inc has consistently demonstrated innovation and cutting-edge technology in its products and services, garnering recognition and accolades from industry experts. Its constant focus on customer satisfaction and strategic partnerships has further cemented Nov Inc's position as a market leader. With a track record of success and continuous development, Nov Inc has successfully established itself as a reliable and trustworthy company in the stock market.

Nov Inc is primarily present in several countries and regions. These include the United States, Europe, Asia, and South America. With a global presence, Nov Inc has established a strong foothold in markets worldwide, allowing it to cater to a diverse range of customers and capitalize on international business opportunities. By expanding its operations across different countries and regions, Nov Inc demonstrates its commitment to growth and maximizing its global reach. Through its presence in these various locations, Nov Inc is able to better serve its customers and adapt to different market dynamics, ensuring its continued success and competitiveness in the stock market.

Nov Inc is a leading company that embodies strong values and a progressive corporate philosophy. With a focus on innovation, Nov Inc strives to constantly exceed customer expectations and deliver cutting-edge solutions. The company's core values revolve around integrity, teamwork, and customer centricity. Nov Inc fosters a culture of continuous learning and growth, encouraging its employees to think outside the box and push boundaries. Their commitment to sustainability and social responsibility is evident in their initiatives towards environmental conservation and community development. Nov Inc's unwavering dedication to excellence makes it a reliable choice for investors seeking a forward-thinking and ethically-driven company.

Analüütikud määravad Nov aktsiale keskmiseks hinnasihi 21,80 USD (mediaan: 21,00 USD), mis on +13,0 % viimase hinna suhtes. Konsensus põhineb 23 analüütiku hinnangul.

23 analüütikut hindavad praegu Nov aktsiat: 10 soovitab osta, 11 hoida ja 2 müüa. 2026. aastaks ootavad analüütikud, et Nov teenib tulu 8,68 B USD ja kasumit aktsia kohta 0,91 USD.

Praeguse kursiga kaubeldakse Nov aktsiaga 17,29 EUR (19,29 USD) juures.

Nov aktsia (NOV) on noteeritud 6 börsil, sh: NYSE (NOV), London (0K58.L), SIX (Zürich) (NO1V.SW), Frankfurt (NO8.F), München (NO8.MU), Düsseldorf (NO8.DU).

Nov Inc is a leading provider of innovative business solutions. The company specializes in three core areas: medical technology, sensor technology, and electromobility. Nov Inc offers its customers a comprehensive portfolio of products and services. Nov Inc's medical technology division specializes in the development and production of state-of-the-art medical devices and instruments. These include endoscopes, sonography devices, ultrasound devices, and patient monitors. Nov Inc's products are particularly user-friendly and are characterized by the highest quality and precision. In the field of sensor technology, Nov Inc offers a wide range of measuring instruments. These range from simple sensors for monitoring pressure, temperature, humidity, or motion to more complex applications for the automotive industry or aerospace. Nov Inc's sensors enable precise measurement and thus ensure reliable control of systems and devices. As a third business field, Nov Inc is dedicated to electromobility. The company develops innovative solutions for the propulsion of electric cars and other vehicles. This includes not only motors but also control systems and battery technology. With its products, Nov Inc makes an important contribution to environmental protection and sustainable transportation. In addition to these three market-driven divisions, Nov Inc is also an important player in the field of research and development. The company works closely with universities and institutes to develop innovative ideas and technologies. These are then commercialized and offered on the market in various business areas of Nov Inc. Nov Inc's business model is based on high innovation and continuous adaptation to the changing needs of the market. The company relies on the high quality of its products and services as well as close collaboration with customers and partners. With its wide range of products and services, its focus on research and development, and its high innovation power, Nov Inc is an important player in many industries. The company is committed to further expanding its market position and thus offering its customers even better solutions and innovations.

oodatav Nov käive on 8,68 B USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

oodatav Nov kasum on 335,24 M USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) Nov jaoks on praegu 21,12. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Nov aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) Nov jaoks on praegu 0,82. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Nov aktsia jaoks.

Eulpooli kvaliteedinäitaja Nov jaoks on 4/10.

Nov ISIN on US62955J1034. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Nov WKN on A2QLRE. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.

Nov ticker on NOV. Ticker-sümbol kasutatakse Nov aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
19,87 USD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Sektor
Tööstus
Energiavarustus ja teenused
Aktsiate arv
Töötajad
Tulu töötaja kohta
982 471,91 USD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait nov.com
Valuuta
USD
Börsi noteerimise algus
29. okt 1996
ISIN
US62955J1034
CUSIP
62955J103
SEDOL
BN2RYW9
Turukapitalisatsioon
6,95 B USDMid Cap
52-nädala vahemik
PEG
3,08
P/E suhe
P/E e 2026
20,74
P/E e 2027
15,24
P/E e 2028
12,86
P/E e 2029
10,90
P/E e 2030
9,94
P/S
P/S e
0,82
EV/EBIT
10,33
P/B suhe
1,11
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
1,76 %
Dividend
Dividendi tootlus
2,64 %
Prognoositud dividendi tootlus
1,87 %
Väljamaksmise suhe
129,08 %
Dividendi kasv Ø5Y
12,47 %
Dividendimaksed aastas
5
Dividend makstud alates
17 aastat
Dividenti ei ole vähendatud alates
5 aastat
Dividenti on suurendatud alates
2 aastat
Dividendi mahaarvamismaks
30,00 %
Viimati värskendatud 2. nov 2026, 23:58

Nov Börsiticker

DÜSSELDORF · NO8.DUFRANKFURT · NO8.FLONDON · 0K58.LMÜNCHEN · NO8.MUNEW YORK · NOVSIX · NO1V.SW

Nov FIGI

NOV:US · BBG000BJX8C8NOV:UA · BBG000BJX8W6NOV:UC · BBG000BJX9X3NOV:UN · BBG000BJXC48NOV:UP · BBG000BJXCC9NOV:UB · BBG000BJXD55NOV:UT · BBG000BJXFS5NOV:UM · BBG000BJXG67NOV:UX · BBG000BJXH56NOV:UD · BBG000BJXKW9NOV:UF · BBG000BJXLW7NOV:VY · BBG000BJXM91

Kõik teised näitajad ja analüüsid Nov kohta sügavamalt

Meie Nov-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Nov. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: